CAS NO: | 78950-78-4 |
包装 | 价格(元) |
10 mM * 1 mL in DMSO | 电议 |
5mg | 电议 |
10mg | 电议 |
25mg | 电议 |
50mg | 电议 |
100mg | 电议 |
200mg | 电议 |
500mg | 电议 |
生物活性 | 8-OH-DPAT is a potent and selective5-HTagonist, with apIC50of 8.19 for 5-HT1A and aKiof 466 nM for 5-HT7; 8-OH-DPAT weakly binds to 5-HT1B (pIC50, 5.42), 5-HT (pIC50<5). | ||||||||||||||||
IC50& Target |
| ||||||||||||||||
体外研究 (In Vitro) | 8-OH-DPAT is a potent and selective 5-HT agonist, with a pIC50of 8.19 for 5-HT1A; weakly binds to 5-HT1B (pIC50, 5.42), 5-HT (pIC50<5)[1]. 8-OH-DPAT has high affinity at 5-HT7 with a Kiof 466 nM, and does not bind to 5-HT6 or 5-HT4[2]. | ||||||||||||||||
体内研究 (In Vivo) | 8-OH-DPAT (1 mg/kg) normalizes hypolocomotion, significantly increases wakefulness and reduces the duration of REM sleep without effect on the duration of non-REM sleep in the dark period in orexin knockout (KO) mice. 8-OH-DPAT shows no obvious effect on wakefulness or the duration of either REM sleep or non-REM sleep in WT mice. 8-OH-DPAT (1 mg/kg, s.c.) activates 5-HT1A receptor in orexin knockout mice[3]. | ||||||||||||||||
分子量 | 247.38 | ||||||||||||||||
性状 | Solid | ||||||||||||||||
Formula | C16H25NO | ||||||||||||||||
CAS 号 | 78950-78-4 | ||||||||||||||||
运输条件 | Room temperature in continental US; may vary elsewhere. | ||||||||||||||||
储存方式 |
| ||||||||||||||||
溶解性数据 | In Vitro: DMSO : 100 mg/mL(404.24 mM;Need ultrasonic) 配制储备液
* 请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效。 In Vivo: 请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂: ——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用;
以下溶剂前显示的百
|